The cell surface activating receptor NKp30 was up-regulated in Vδ1 T cells and Vδ2 T cells of patients with advanced HCC, and TIM3 was up-regulated in circulating γδ T cells of patients with advanced HCC. Here, NCR3 is linked to hepatocellular carcinoma.